CCL17 and IL-10 as Effectors That Enable Alternatively Activated Macrophages to Inhibit the Generation of Classically Activated Macrophages

Journal of Immunology

Volumn 172, Issue 3, 2004, Pages 1407-1413

  Katakura, Tatsushi ^a   Miyazaki, Masaru ^b   Kobayashi, Makiko ^a,c   Herndon, David N ^c   Suzuki, Fujio ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b CHIBA UNIVERSITY   (Japan)

^c SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCL 17; CYTOKINE; DNA; INTERLEUKIN 10; INTERLEUKIN 6; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY SURFACE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; CPG ISLAND; CULTURE MEDIUM; EFFECTOR CELL; HOST; IMMUNE DEFICIENCY; INFECTION RESISTANCE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM EXUDATE; PRIORITY JOURNAL; THERMAL INJURY;

EID: 1642526354     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.3.1407     Document Type: Article

References (49)

1. Gordon. S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23.
2. Mosser, D. M. 2003. The many faces of macrophage activation. J. Leukocyte Biol. 73:209.
3. + T cells in vitro. Immunology 92:478.
4. Goerdt, S., and C. E. Orfanos. 1999. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10:137.
5. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and P. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23:549.
6. Aderem, A., and D. M. Underhill. 1999. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17:593.
7. Lopes, M. F., C. G. Freire-de-Lima, and G. A. DosReis. 2000. The macrophage haunted by cell ghosts: a pathogen grows. Immunol. Today 21:489.
8. Katakura, T., M. Kobayashi, H. Takahashi, D. N. Herndon, R. B. pollard, and F. Suzuki. 2002. Human peripheral blood monocytes as anti-MRSA effector cells in a human-SCID chimera model. J. Interferon Cytokine Res. 22: S197.
9. Matsumoto, K., Y. Osada, T. Une, T. Otani, H. Ogawa, and I. Azuma. 1987. Anti-infectious activity of the synthetic muramyl dipeptide analogue MDP-Lys (L-18). In Immunostimulants, Now and Tomorrow. Japan Scientific Society Press, Tokyo, p. 79.
10. Suzuki, F., R. B. Pollard, S. Uchimura, T. Munakata, and H. Maeda. 1990. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinoslatin. Cancer Res. 50:3897.
11. Cella, M., M. Salio, Y. Sakakibara, H. Langen, H. Julkunen, and A. Lanzavecchia. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:821.
12. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709.
13. Mills, C. D., K. Kincaid, J. M. Heilman, and A. M. Hill. 2000. M1/M2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164:6166.
14. Katakura, T., M. Kobayashi, D. N. Herndon, R. B. Pollard, and F. Suzuki. 2002. Macrophages from thermally injured mice biologically different from macrophages from normal mice. J. Interferon Cytokine Res. 22:S198.
15. 1-Acid glycoprotein (AGP) stimulates resident macrophages to generate alternatively activated macrophages (AAMφ). Part 1. Biological properties of AGP-induced AAMφ. FASEB J. 17:C160.
16. Schwacha, M. G. 2003. Macrophages and post-burn immune dysfunction. Burns 29:1.
17. Stein, M., S. Keshav, N. Harris, and S. Gordon. 1992. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176:287.
18. Hogger, P., J. Dreier, A. Droste, F. Buck, and C. Sorg. 1998. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J. Immunol. 161:1883.
19. Shibata, Y., E. Shibuya, and N. Ishida. 1984. Relationships between suppressor macrophages and macrophage precursors in the spleens from tumor-bearing mice. Cell. Immunol. 85:45.
20. Orlikowsky, T., Z. Q. Wang, A. Dudhane, H. Horowitz, B. Conti, and M. Hoffmann. 1996. The cell surface marker phenotype of macrophages from HIV-1-infected subjects reflects an IL-10-enriched and IFN-γ-deprived donor environment. J. Interferon Cytokine Res. 16:957.
21. Utaisincharoen, P., N. Anuntagool, P. Chaisuriya, S. Pichyangkul, and S. Sirisinha. 2002. CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264.7). Clin. Exp. Immunol. 128:467.
22. Takagi, K., F. Suzuki, R. E. Barrow, S. E. Wolf, M. Kobayashi, and D. N. Herndon. 1998. Growth hormone improves the resistance of thermally injured mice infected with herpes simplex virus type 1. J. Trauma 44:517.
23. Furukawa, K., M. Kobayashi, D. N. Herndon, R. B. Pollard, and F. Suzuki. 2002. Appearance of monocyte chemoattractant protein 1 (MCP-1) early after thermally injury: role in the subsequent development of burn-associated type 2 T-cell responses. Ann. Surg. 236:112.
24. Katakura, T., M. Kobayashi, N. J. Robert, Jr., D. N. Herndon, and F. Suzuki. 2003. 2-Carboxyethygermanium sesquioxide (Ge-132) as an inhibitor of alternatively activated macrophages. FASEB J. 17:C290.
25. Chace, J. H., N. A. Hooker, K. L. Mildenstein, A. M. Krieg, and J. S. Cowdery. 1997. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopathol. 84:185.
26. Takeshita, S., F. Takeshita, D. E. Haddad, K. J. Ishii, and D. M. Klinman. 2000. CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression. Cell. Immunol. 206:101.
27. Vazquez-Torres, A., and F. C. Fang. 2001. Oxygen-dependent anti-Salmonella activity of macrophages. Trends Microbiol. 9:29.
28. Greaves, D. R., T. Hakkinen, A. D. Lucas, K. Liddiard, E. Jones, C. M. Quinn, J. Senaratne, F. R. Green, K. Tyson, J. Boyle, et al. 2001. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus-and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 21:923.
29. Raveh, D., B. A. Kruskal, J. Farland, and R. A. Ezekowitz. 1998. Th1 and Th2 cytokines cooperate to stimulate mannose-receptor-mediated phagocytosis. J. Leukocyte Biol. 64:108.
30. Anderson, C. F., and D. M. Mosser. 2002. Cutting edge: biasing immune responses by directing antigen to macrophage Feγ receptors. J. Immunol. 168:3697.
31. Lissner, C. R., R. N. Swanson, and A. D. O'Brien. 1983. Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the 1ty gene in peritoneal and splenic macrophages isolated in vitro. J. Immunol. 131:3006.
32. Nakajima, H., M. Kobayashi, R. B. Pollard, and F. Suzuki. 2001. Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses. J. Leukocyte Biol. 70:374.
33. Loke, P., A. S. MacDonald, A. Robb. R. M. Maizels, and J. E. Allen. 2000. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur. J. Immunol. 30:2669.
34. Vodovotz, Y., C. Bogdan, J. Paik, Q. W. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J. Exp. Med. 178:605.
35. Langermans, J. A., P. H. Nibbering, M. E. Van Vuren-Van Der Hulst, and R. Van Furth. 2001. Transforming growth factor-β suppresses interferon-γ-induced toxoplasmastatic activity in murine macrophages by inhibition of tumor necrosis factor-α production. Parasite Immunol. 23:169.
36. Boutard, V., R. Havouis, B. Fouqueray, C. Philippe, J. P. Moulinoux, and L. Baud. 1995. Transforming growth factor-β stimulates arginase activity in macrophages: implications for the regulation of macrophage cytotoxicity. J. Immunol. 155:2077.
37. Johnston, J. A., and J. J. O'Shea. 2003. Matching SOCS with function. Nat. Immunol. 4:507.
38. Niemand, C., A. Nimmesgem, S. Haan, P. Fischer, F. Schaper, R. Rossaint, P. C. Heinrich, and G. Muller-Newen. 2003. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J. Immunol. 170:3263.
39. Berlato, C., M. A. Cassatella, I. Kinjyo, L. Gatto, A. Yoshimura, and F. Bazzoni. 2002. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. 168:6404.
40. Alexander, W. S. 2002. Suppressors of cytokine signaling (SOCS) in the immune system. Nat. Rev. Immunol. 2:410.
41. Sandoval-Lopez, G., and L. M. Teran. 2001. TARC: novel mediator of allergic inflammation. Clin. Exp. Allergy 31:1809.
42. Sekiya, T., Y. Tsunemi, M. Miyamasu, K. Ohta, A. Morita, H. Saeki, K. Matsushima, O. Yoshie, N. Tsuchiya, M. Yamaguchi, et al. 2003. Variations in the human Th2-specific chemokine TARC gene. Immunogenetics 54:742.
43. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129.
44. Imai, T., M. Nagira, S. Takagi, M. Kakizaki, M. Nishimura, J. Wang, P. W. Gray, K. Matsushima, and O. Yoshic. 1999. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine Int. Immunol. 11:81.
45. Kawasaki, S., H. Takizawa, H. Yoneyama, T. Nakayama, R. Fujisawa, M. Izumizaki, T. Imai, O. Yoshie, I. Homma, K. Yamamoto, and K. Matsushima. 2001. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J. Immunol. 166:2055.
46. Sester, D. P., K. J. Stacey, M. J. Sweet, S. J. Beasley, S. L. Cronau, and D. A. Hume. 1999. The actions of bacterial DNA on murine macrophages. J. Leukocyte Biol. 66:542.
47. Krieg, A. M. 2003. CpG motifs: the active ingredient in bacterial extracts? Nat. Med. 9:831.
48. Rothfuchs, A. G., D. Gigliotti, K. Palmblad, U. Andersson, H. Wigzell, and M. E. Rottenberg. 2001. IFN-αβ-dependent. IFN-γ secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J. Immunol. 167:6453.
49. Song, E., N. Ouyang, M. Horbelt, B. Antus, M. Wang, and M. S. Exton. 2000. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell. Immunol. 204:19.